ADHD

Trial failure deals harsh blow to Alcobra
BioPharma Dive
Wed, 01/18/17 - 09:56 am
Alcobra
clinical trials
Metadoxine
ADHD
FDA to withdraw approval of Lannett's generic ADHD drug
Bizjournals.com
Thu, 10/20/16 - 09:30 am
FDA
Lannett
generics
ADHD
Concerta
JNJ
Janssen
Shire Could Divest ADHD Treatment, Other Assets, for More Upside Post-Baxalta
TheStreet.com
Thu, 07/14/16 - 07:21 pm
Shire
ADHD
Baxalta
Brexit
M&A
Vyvanse
Acetaminophen Use During Pregnancy Linked To Autism and ADHD in Children
Xtalks
Wed, 07/6/16 - 11:10 am
acetaminophen
pregnancy
autism
ADHD
Shire looks for more ADHD mileage with new data on long-acting prospect
Fierce Pharma
Wed, 07/6/16 - 09:53 am
Shire
ADHD
SHP465
Shire's adult ADHD drug shows promise in late-stage study
BioPharma Dive
Fri, 07/1/16 - 09:44 am
Shire
ADHD
SHP465
clinical trials
It’s tasty and easy to take. And that’s why a new ADHD drug alarms some psychiatrists
Stat
Mon, 05/23/16 - 07:12 pm
ADHD
Neos
Adzenys
Neos Therapeutics: On The Right Track, But Don't Expect Much From Adzenys This Year
Seeking Alpha
Fri, 05/20/16 - 10:32 am
Neos
Adzenys
ADHD
With weight-control peers flailing, Shire keeps growing Vyvanse
Fierce Pharma
Thu, 05/12/16 - 09:43 am
Shire
Vyvanse
obesity
ADHD
FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval
Fierce Biotech
Tue, 10/20/15 - 09:44 am
FDA
Neos
Ritalin
ADHD
Cotempla XR-ODT
3 ADHD Treatment Makers to Watch
Motley Fool
Mon, 10/12/15 - 08:49 am
ADHD
Shire
JNJ
Eli Lilly
Shire chalks up victory in Vyvanse patent battle
Fierce Pharma
Fri, 09/25/15 - 08:47 pm
Shire
Vyvanse
patents
ADHD
generics
FDA warns Pearson on ADHD device claims
Mass Device
Thu, 09/24/15 - 08:56 am
FDA
ADHD
devices
NSC Pearson
Quotient ADHD
Shire's once-daily extended-release ADHD drug now approved in Europe
BioPharma Dive
Tue, 09/22/15 - 11:35 am
Shire
ADHD
Intuniv
Europe
Vyvanse set to steal ADHD share in back-to-school meds rush
Fierce Pharma Marketing
Wed, 08/19/15 - 12:17 pm
ADHD
Vyvanse
Shire
JNJ
Concerta
Neos pulls off a $72M IPO to push its ADHD drugs forward
Fierce Biotech
Fri, 07/24/15 - 05:47 pm
Neos
IPOs
ADHD
Neos angles for a $74M IPO to fund its ADHD drugs
Fierce Biotech
Mon, 07/13/15 - 11:44 am
Neos
ADHD
IPOs
American Adults Surpass Children in the Use of ADHD Drugs
Bloomberg
Mon, 06/22/15 - 10:51 am
ADHD
FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market
Fierce Pharma
Wed, 06/17/15 - 11:25 am
FDA
generics
Concerta
Mallinckrodt
Actavis
JNJ
ADHD
The FDA's Authority Challenged By Mallinckrodt
Yahoo/Benzinga
Sat, 05/16/15 - 02:06 pm
FDA
Mallinckrodt
JNJ
Concerta
ADHD
generics

Pages